LCID
Lucid Group, Inc.
LCID has the edge over SHOE overall, supported by stronger valuation and stronger fundamentals.
SHOE
Shoe Station Group Inc.
SHOE's outlook is improving despite an expensive valuation.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SHOE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Strong |
SHOE's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
SHOE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.3x | $5.57 | -61% |
| Fair | 9.2x | $8.12 | -43% |
| Forward | 10x | $14.20 | — |
| Expensive | 15x | $13.27 | -6.5% |
| Current | 16x | $14.20 | — |
Historical ranges are pointers, not guarantees.
SHOE's PE is in its expensive range at 16x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its fair range.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
SHOE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect SHOE's earnings to grow and its profitability to improve, with its revenue holding steady.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
SHOE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.39 | +58% |
| Q3 2026 | $0.88 | -61% |
| Q2 2026 | $1.35 | -44% |
| Q1 2026 | $1.90 | -29% |
| Q4 2025 | $2.10 | -23% |
| Q3 2025 | $2.27 | -20% |
| Q2 2025 | $2.39 | -12% |
| Q1 2025 | $2.68 | 0% |
| Q4 2024 | $2.72 | -6.2% |
SHOE has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over SHOE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
SHOE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $284.3M | -7.2% |
| Q2 2026 | $270.7M | -2.5% |
| Q1 2026 | $254.1M | -3.4% |
| Q4 2025 | $297.2M | -3.2% |
| Q3 2025 | $306.4M | -7.9% |
| Q2 2025 | $277.7M | -7.5% |
| Q1 2025 | $262.9M | -6.1% |
| Q4 2024 | $306.9M | -4.1% |
SHOE's revenue has slid since its 2021 peak: $284M last quarter, down 7.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.7% | -5.6 points |
| Q2 2026 | -2.2% | -6.5 points |
| Q1 2026 | 4.3% | -1 points |
| Q4 2025 | 6.3% | -1.7 points |
| Q3 2025 | 8.2% | -0.8 points |
| Q2 2025 | 4.3% | -3.2 points |
| Q1 2025 | 5.3% | -1.8 points |
| Q4 2024 | 8% | -0.7 points |
SHOE has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
SHOE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.5M | +197% |
| Q2 2026 | $12.6M | +$35.6M |
| Q1 2026 | $27.7M | -24% |
| Q4 2025 | $19.7M | +138% |
| Q3 2025 | $2.2M | -88% |
| Q2 2025 | -$23M | -435% |
| Q1 2025 | $36.2M | -11% |
| Q4 2024 | $8.3M | -76% |
SHOE has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
SHOE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -72K shares |
| 1 year | -0.5% | -140K shares |
| 3 years | -0.3% | -95K shares |
| 5 years | -4.7% | -1.3M shares |
| Available history | -6.2% | -1.8M shares |
SHOE has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $7M |
| Q1 2025 | — |
| Q1 2024 | — |
| Q4 2023 | $5.4M |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SHOE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.8x | Net Cash |
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -1.2x | Net Cash |
| Q4 2025 | -0.9x | Net Cash |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -0.9x | Net Cash |
| Q4 2024 | -0.6x | Net Cash |
SHOE has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SHOE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.4 | Neutral |
| Stochastic | 71.0 | Neutral |
SHOE's weekly RSI is 45 (neutral) and its Stochastic is 71 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
SHOE PE vs Consumer Cyclical Sector
| Metric | SHOE | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 10% below |
| PE % | 85 | 47 | 38 pts above |
SHOE is trading at 16x earnings, a 10% discount to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
SHOE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.7 | 3.6% above |
| 20 week MA | $14.2 | 0.1% below |
| 50 week MA | $16.6 | 14% below |
| 100 week MA | $19.2 | 26% below |
| 200 week MA | $24.7 | 42% below |
SHOE has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
SHOE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.4 | $19.4 | +5.3% |
| 2021 | $19.4 | $39.3 | +102% |
| 2022 | $39.3 | $24.5 | -38% |
| 2023 | $24.5 | $30.2 | +23% |
| 2024 | $30.2 | $35.7 | +18% |
| 2025 | $35.7 | $18.1 | -49% |
| 2026 YTD | $18.1 | $14.2 | -21% |
SHOE has the edge over LCID on returns for 2026, with the stronger performance.